Cargando…
1,25-Dihydroxyvitamin D Inhibits LPS-Induced High-Mobility Group Box 1 (HMGB1) Secretion via Targeting the NF-E2-Related Factor 2–Hemeoxygenase-1–HMGB1 Pathway in Macrophages
1,25-Dihydroxyvitamin D [1,25(OH)(2)D(3)] is recognized as a key mediator of inflammatory diseases, including sepsis. Clinical studies demonstrate that 1,25 (OH)(2)D(3) protects patients from sepsis, but clinical treatment with 1,25(OH)(2)D(3) is rare. In this study, we report that 1,25(OH)(2)D(3) t...
Autores principales: | Rao, Zebing, Zhang, Na, Xu, Ning, Pan, Ying, Xiao, Mengjun, Wu, Junxian, Zhou, Hong, Yang, Shuo, Chen, Yunzi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650703/ https://www.ncbi.nlm.nih.gov/pubmed/29085368 http://dx.doi.org/10.3389/fimmu.2017.01308 |
Ejemplares similares
-
Corrigendum: 1,25-Dihydroxyvitamin D Inhibits LPS-Induced High-Mobility Group Box 1 (HMGB1) Secretion via Targeting the NF-E2-Related Factor 2–Hemeoxygenase-1–HMGB1 Pathway in Macrophages
por: Rao, Zebing, et al.
Publicado: (2018) -
High mobility group box 1 (HMGB1) quantified by ELISA that dose not cross-react with HMGB2
por: Yakabe, K, et al.
Publicado: (2005) -
Inhibition of HMGB1/RAGE-mediated endocytosis by HMGB1 antagonist box A, anti-HMGB1 antibodies, and cholinergic agonists suppresses inflammation
por: Yang, Huan, et al.
Publicado: (2019) -
HMGB1, anti-HMGB1 antibodies, and ratio of HMGB1/anti-HMGB1 antibodies as diagnosis indicator in fever of unknown origin
por: Chen, Mingkun, et al.
Publicado: (2021) -
Cross-reactivity of anti-HMGB1 antibodies for HMGB2
por: Davies, Jessica E., et al.
Publicado: (2018)